Glanbia plc 2018 Full Year Results Presentation 20 th February, - - PowerPoint PPT Presentation

glanbia plc
SMART_READER_LITE
LIVE PREVIEW

Glanbia plc 2018 Full Year Results Presentation 20 th February, - - PowerPoint PPT Presentation

Glanbia plc 2018 Full Year Results Presentation 20 th February, 2019 Siobhn Talbot, Mark Garvey, Group Managing Director Group Finance Director This presentation contains forward-looking statements. These statements have been made by the


slide-1
SLIDE 1

Glanbia plc

2018 Full Year Results Presentation

20th February, 2019

Siobhán Talbot, Mark Garvey, Group Managing Director Group Finance Director

slide-2
SLIDE 2

This presentation contains forward-looking statements. These statements have been made by the Directors in good faith based on the information available to them up to the time of their approval of this presentation. Due to the inherent uncertainties, including both economic and business risk factors underlying such forward-looking information, actual results may differ materially from those expressed or implied by these forward- looking statements. The Directors undertake no obligation to update any forward-looking statements contained in this presentation, whether as a result of new information, future events, or otherwise.

2

slide-3
SLIDE 3
slide-4
SLIDE 4

4

Delivering our financial ambition

Financial Metrics 2018 – 2022 Ambition* 2018 Result Achieved Summary

Total group Revenue by 2022 €5bn €3.7bn Total Group Revenue +4.6%

  • Adj. EPS growth

5% - 10% +9% Driven by growth platforms ROCE 10% - 13% 13.2% Focused capital allocation OCF Conversion > 80% 92.0% Strong execution Dividend Payout Ratio 25% - 35% 26.6% Dividend +10%

*Ambitions have been updated for IFRS 15 - refer to slide 23 for updated ambition Unless clearly identified all revenue and profit movements in this presentation are on a constant currency basis. A reconciliation of constant currency and reported movements is contained in the Appendix of this presentation

slide-5
SLIDE 5

5

Strategic Pillars

Innovation central to our success

Protect and grow the core Embed enablers across the business

Investing in digital DTC platform Growing our presence in Emerging markets Ongoing talent development

Selectively build and scale beyond the core

Acquisitions Growth in JVs via capital efficient model

Health and wellness On-the-go food and beverages Digitally connected Clean labelling

Powerful consumer trends driving our business

Global Macro Trends

GPN like-for-like Branded volume +9.2% Nutritional Solutions volume +8.5%

Group focused and aligned to drive growth

slide-6
SLIDE 6
slide-7
SLIDE 7

7

Revenue

€1,180m

+9.5%

LFL Branded volume

+9.2%

Growth

EBITA

€173.1m

+6.7%

EBITA margin

14.7%

  • 40 bps

Performance

Innovation ahead of target Strong demand driving growth in all regions Margins in-line with long- term guidance

slide-8
SLIDE 8

Portfolio continues to evolve

8

Channel shift to Online & FDMC Emerging markets driving strong growth Innovation around core formats & lifestyle driving growth

71% 63% 15% 14%

5% 14% 5% 5% 4% 4%

2015 2018

Format Mix

Share of Revenue

RTE RTD Protein Energy CAPS/TABS RTM

36% 26% 32% 25% 22% 28%

10% 21%

2015 2018

Channel Mix

Share of Revenue

Specialty Distributor Online FDMC

35% 39% 65% 61% 2015 2018

Regional Mix

Share of Revenue

Rest of the World North America

slide-9
SLIDE 9

Excellent addition to the portfolio

9

FY 2018 pro-forma revenue $247m +17% Great brand to participate in $8 billion weight management category Market leading position in RTD in the US & UK Further platform for innovation

slide-10
SLIDE 10

NS growth driven by customers seeking:

Protein Functionality Convenience Clean Label

10

€1,207m

  • 0.6%

Nutritional Solutions Revenue

+3.0%

Revenue

US Cheese Revenue

  • 3.1%

€111.8m +3.0%

Nutritional Solutions EBITA margin

Mid-teens

EBITA

US Cheese EBITA margin

Low-to-mid single digits

Nutritional Solutions (NS) delivers 8.5% volume growth US Cheese earnings largely protected by operating model

slide-11
SLIDE 11

Driving growth in Nutritional Solutions

11

Agreed purchase price $89m

Complementary technologies & supply chain to Nutritional Solutions Customers across personal care and food sectors 2018 Revenue $101m US based with 3 sites in CT & IL Expected to close by Q2 2019 Marginally earnings accretive to FY 2019 results US based non-dairy ingredients solutions Global & Regional customer base

slide-12
SLIDE 12
slide-13
SLIDE 13

13

  • 1. Average adjusted EPS as reported on a constant currency basis over the 5 year period 2014 to 2018
  • 2. Average ROCE over the 5 year period 2014 to 2018 is based on a reported ROCE in each financial year and adjusted for deferred tax in prior years to ensure like-for-

like comparison with 2017 & 2018

  • 3. Operating Cash Flow (“OCF”) conversion is defined as Operating Cash Flow divided by pre-exceptional EBITDA. The 2014 – 2018 metric takes the averages of OCF

conversion over the period. In 2017, pro-forma cash-flow figures were used to reflect the disposal of 60% of Dairy Ireland

  • 4. Dividend Payout Ratio is defined as Dividend Per Share divided by Adjusted Earnings Per Share. The 2014 – 2018 metric takes the averages of the Dividend Payout

Ratio over the period. In 2017, pro-forma Adjusted EPS was used in the calculation of Dividend Payout Ratio. Dividend per share for 2018 is 24.2c (2017: 22.0c)

Financial Metrics 2014 – 2018 Result 2018 – 2022 Ambition 2018 Result Achieved

  • Adj. EPS growth

10.2%1 5% - 10% 9% ROCE 13.9%2 10% - 13% 13.2% OCF Conversion 84.7%3 > 80% 92.0% Dividend Payout Ratio 20.1%4 25% - 35% 26.6%

slide-14
SLIDE 14

14

2018 results summary Pre-exceptional €’m Reported currency

2018 2017 Change Revenue (Wholly-owned) 2,386.3 2,387.1 (0.8) EBITA (Wholly-owned) 284.9 283.2 +1.7 EBITA margin 11.9% 11.9% +0 bps Amortisation (45.9) (43.1) Net Finance Costs (17.5) (23.0) Share of Joint Ventures 45.3 42.8 Income Tax (32.8) (38.3) Profit for the period (pre-exceptional) 234.0 221.6 Adjusted EPS* 91.0c 87.1c +3.9c

Constant currency

2018 +4.1% +5.2% +10 bps +9.0%

*2017 Adjusted EPS is on a pro-forma basis for continuing operations. It eliminates the impact of discontinued operations.

slide-15
SLIDE 15

15

Wholly Owned Revenue €’m Reported currency Constant currency 2018 2017 % Change % Change

Glanbia Performance Nutrition 1,179.6 1,121.1 +5.2% +9.5% Nutritional Solutions 526.7 531.9 (1.0%) +3.0% US Cheese 680.0 734.1 (7.4%) (3.1%) Glanbia Nutritionals 1,206.7 1,266.0 (4.7%) (0.6%) Wholly Owned Revenue 2,386.3 2,387.1 (0.0%) +4.1%

slide-16
SLIDE 16

16

€1,121m 9.1% 4.5% (3.9%) (4.1%) €1,180m

€750m €850m €950m €1,050m €1,150m €1,250m FY17 FX Volume Price Acquisitions FY18

slide-17
SLIDE 17

17

€532m 8.5% (3.8%) (5.5%) €527m

€490m €510m €530m €550m FY17 FX Volume Price FY18

Nutritional Solutions

€734m 1.7% (4.4%) (4.8%) €680m

€630m €650m €670m €690m €710m €730m €750m FY17 FX Volume Price FY18

US Cheese

slide-18
SLIDE 18

€328m €32m €4m (€10m) (€16m) (€42m) €302m €295m

€200m €220m €240m €260m €280m €300m €320m €340m 2018 EBITDA Working Capital Business Sustaining Capex 2018 Operating Cash Flow Net Interest & Tax Dividends from JV&A's Other FCF 2018

18

slide-19
SLIDE 19

€32m €24m €16m €57m €49m €46m €15m

Amazing Grass & Body & Fit

€168m

SlimFast

€313m

2016 2017 2018

19

€417m €241m €104m

Total Investment Investments in JVs Strategic Capex Sustaining Capex

2018 Return on Capital Employed 13.2%

Investment in JV’s

€42m

Acquisitions 2018-2022 Ambition - Return on Capital Employed 10% - 13%

slide-20
SLIDE 20

PLC’s total commitments to projects set-out above: €105m

20

Capital efficient model for Glanbia to leverage its leading positions in dairy

2018 update Strategic update

Ring-fenced financing model using non-recourse bank funding

$470m cheese & whey facility USA €130m mozzarella facility Ireland €140m continental cheese plant Ireland Michigan JV Glanbia Cheese EU Glanbia Ireland A-Ware Share of JV PAT

€45.3m +7.1%

Cash Dividends received

€32m

slide-21
SLIDE 21

21

Balance Sheet FY 2018 FY 2017

Net Debt €576.7m €367.7m Net Debt / Adj. EBITDA 1.55x 1.07x

  • Adj. EBIT / Net Financing Costs

14.8x 11.2x*

Net debt increased by €209m, raising the Net Debt to Adjusted EBITDA ratio to 1.55 times, mainly due to the acquisition of SlimFast Total available Banking Facilities €1.1bn with average maturity of 3.8 years (2017: 2.2 years) Strong financing cost cover at 14.8 times Net pension obligations of €38.5m at year end, down from €41.9m in 2017

*Pre-exceptional costs (7.0x reported)

slide-22
SLIDE 22

Pro-forma impact on 2018 results

22

€’m Glanbia Nutritionals 2018 Reported IFRS 15 impact 2018 Pro-forma

Nutritional Solutions €527m €50m €577m US Cheese €680m €734m €1,414m Total Revenue €1,207m €784m €1,991m EBITA €112m €112m EBITA margins 9.3% 5.6%

IFRS 15 will be effective for FY 2019 Impacts Glanbia Nutritionals reported revenue and EBITA margin percentage. No impact to EBITA Recognition of 100% of Southwest Cheese sales within Glanbia Nutritionals

slide-23
SLIDE 23

23

WHOLLY OWNED

SHARE OF REVENUE

GPN €1.8bn Nutritional Solutions €1.0bn Joint Ventures €1.2bn US Cheese €2.0bn Revenue ambition by 2022 €6 billion*

13% - 15%

Low-to- mid single digits

13% - 15%

Average 5 year EBITA Margin** 2018 to 2022

Updated for IFRS 15

*Glanbia held a Capital Markets Day on 23 May 2018 where it set out its revenue and margin ambition to 2022. The table above updates this for the adoption of IFRS 15 which will take place in 2019. It is also retranslated based on current foreign exchange rates **As a result of the adoption of IFRS 15, margin ambition in Nutritional Solutions has been reduced from 14% - 16% to 13% - 15% and in US Cheese from mid-single digits to low-to-mid single digits. There is no change to GPN margin

slide-24
SLIDE 24
slide-25
SLIDE 25

25

FX tailwinds – up to 3% based on current rates Positive outlook for FY 2019 Adjusted EPS is expected to grow by 5% - 8% constant currency Key financial metrics expected to be in-line with 2022 ambition

slide-26
SLIDE 26
slide-27
SLIDE 27

27

The Group reports certain performance measures that are not defined under IFRS but which represent additional measures used by the Board of Directors and the Glanbia Operating Executive in assessing performance and for reporting both internally and to shareholders and other external users. The Group believes that the presentation of these non-IFRS performance measures provides useful supplemental information which, when viewed in conjunction with our IFRS financial information, provides readers with a more meaningful understanding of the underlying financial and operating performance of the Group.

  • 1. While the Group reports its results in euro, it generates a significant proportion of its earnings in currencies other than euro, in particular US dollar. Constant currency reporting is used

by the Group to eliminate the translational effect of foreign exchange on the Group's results. To arrive at the constant currency year-on-year change, the results for the prior year are retranslated using the average exchange rates for the current year and compared to the current year reported numbers

  • 2. The Group has a number of strategically important Equity accounted investees (Joint Ventures) which when combined with the Group’s wholly owned businesses give an important

indication of the scale and reach of the Group’s operations. Total Group is used to describe certain financial metrics such as Revenue and EBITA when they include both the wholly

  • wned businesses and the Group's share of Equity accounted investees
  • 3. Revenue comprises sales of goods and services of the wholly owned businesses to external customers net of value added tax, rebates and discounts
  • 4. EBITA is defined as earnings before interest, tax and amortisation
  • 5. EBITA margin is defined as EBITA as a percentage of revenue
  • 6. EBITDA is defined as earnings before interest, tax, depreciation (net of grant amortisation) and amortisation
  • 7. Adjusted EPS is defined as the net profit attributable to the equity holders of Glanbia plc, before exceptional items and intangible asset amortisation (excluding amortisation of software

costs), net of related tax, divided by the weighted average number of ordinary shares in issue during the year. The calculation of Adjusted Earnings Per Share excludes the cost of software amortisation within the earnings calculation. The Group believes that adjusted EPS is a better measure of underlying performance than Basic EPS as it excludes exceptional items (net of related tax) that are not related to on-going operational performance and intangible asset amortisation, which allows better comparability of companies that grow by acquisition to those that grow organically

  • 8. Pro-forma Adjusted EPS has been provided as the Group believes it is more reflective of the revised and on-going structure of the Group following the disposal of 60% of Dairy Ireland

and related assets in 2017. It is defined as the net profit from continuing operations attributable to the equity holders of Glanbia plc, before exceptional items and intangible asset amortisation (excluding software amortisation), net of related tax, plus the Group’s share (40%) of the profits after tax for Dairy Ireland and related assets, before exceptional items and amortisation of intangible assets (excluding software amortisation), net of related tax, divided by the weighted average number of ordinary shares in issue during the year. Pro-forma Adjusted EPS has been calculated to set out the Adjusted EPS on the basis that the Dairy Ireland transaction had taken place on 1 January 2017.

  • 9. Net debt : adjusted EBITDA is calculated as net debt at the end of the period divided by adjusted EBITDA. Net debt is calculated as total financial liabilities excluding debt issue costs

less cash and cash equivalents. Adjusted EBITDA is calculated as EBITDA for the wholly owned businesses plus dividends received from equity accounted investees, and in the event of an acquisition in the year, includes pro-forma EBITDA as though the acquisition date had been at the beginning of the year. Adjusted EBITDA is a rolling 12 month measure

slide-28
SLIDE 28

28

  • 10. Adjusted EBIT: net finance cost is calculated as pre-exceptional earnings before interest and tax plus dividends received from Equity accounted investees divided by net

finance cost. Net finance cost comprises finance costs less finance income per the Group income statement plus capitalised borrowing costs. Adjusted EBIT and net finance cost are rolling 12 month measures.

  • 11. The Group has adopted an income statement format that seeks to highlight significant items within the Group results for the year. Such items may include restructuring, impairment of

assets, adjustments to contingent consideration, material acquisition integration costs, restructuring costs, profit or loss on disposal or termination of operations, material acquisition costs, litigation settlements, legislative changes, gains or losses on defined benefit pension plan restructuring and profit or loss on disposal of investments. Judgement is used by the Group in assessing the particular items which by virtue of their scale and nature should be disclosed in the income statement and notes as exceptional items

  • 12. Volume increase/(decrease) represents the impact of sales volumes within the revenue movement year-on-year, excluding volume from acquisitions, on a constant currency basis.

Pricing increase/(decrease) represents the impact of sales pricing within the revenue movement year-on-year, excluding acquisitions, on a constant currency basis

  • 13. Like-for-like branded revenue growth represents the sales growth / (decline) year-on-year on branded sales, excluding acquisitions, on a constant currency basis
  • 14. The effective tax rate is defined as the pre-exceptional income tax charge divided by the profit before tax less share of results of Equity accounted investees.
  • 15. The Group defines business sustaining capital expenditure as the expenditure required to maintain/replace existing assets with a high proportion of expired useful life. This

expenditure does not attract new customers or create the capacity for a bigger business. It enables the Group to keep running at current throughput rates but also keep pace with regulatory and environmental changes as well as complying with new requirements from existing customers.

  • 16. The Group defines strategic capital expenditure as the expenditure required to facilitate growth and generate additional returns for the Group. This is generally expansionary

expenditure beyond what is necessary to maintain the Group’s current competitive position.

  • 17. Operating cash conversion is defined as Operating Cashflow (OCF) divided by pre–exceptional EBITDA. Cash conversion is a measure of the Group’s ability to convert trading profits

into cash and is an important metric in the Group’s working capital management programme.

  • 18. ROCE is defined as the Group’s earnings before interest, and amortisation (net of related tax) plus the Group’s share of the results of Equity accounted investees after interest and tax

divided by capital employed. Capital employed comprises the sum of the Group’s total assets plus cumulative intangible asset amortisation less current liabilities less deferred tax liabilities excluding all financial liabilities, retirement benefit assets and cash. It is calculated by taking the average of the relevant opening and closing balance sheet amounts.

  • 19. Dividend payout ratio is defined as the annual dividend per ordinary share divided by the Adjusted Earnings Per Share. The dividend payout ratio for 2017 is defined as the annual

dividend per ordinary share divided by the pro-forma Adjusted Earnings Per Share as the Group believes it is more reflective of the revised and ongoing structure of the Group following the disposal of 60% of Dairy Ireland and related assets in 2017. The dividend payout ratio provides an indication of the value returned to shareholders relative to the Group’s total earnings.

slide-29
SLIDE 29

29

€’m Reported Constant Currency Adjusted Earnings Per Share* FY 2018 FY 2017 FY 2017

Profit attributable to the equity holders of the Company 234.0 231.4 221.8 Amortisation (net of tax)** 34.6 31.7 30.4 Discontinued operations adjusted net income (100%) 0.0 (10.1) (10.1) 40% share of discontinued operations adjusted net income 0.0 4.0 4.0 Pro-forma Adjusted net income 268.6 257.0 246.1 Weighted average number of ordinary shares in issue (millions) 295.2 295.0 295.0 Pro-forma Adjusted Earnings Per Share (cent) 91.01 87.11 83.46 Constant currency growth +9.0%

*This illustrates the adjusted EPS growth year-on-year by comparing 2018 actual results with 2017 pro-forma results which have been re-stated for FX movements. 2017 Pro-forma numbers adjust for the sale of 60% of Dairy Ireland on a continuing basis for FY 2017 **Amortisation and impairment of intangible assets (excluding software amortisation) net of related tax of €6.1 million (2017: €7.5 million)

slide-30
SLIDE 30

30

€’m Reported Constant Currency

Glanbia Performance Nutrition FY 2018 FY 2017 FY 2017 % Change Revenue 1,179.6 1,121.1 1,077.7 +9.5% EBITA 173.1 169.7 162.3 +6.7% EBITA margin 14.7% 15.1% 15.1%

  • 40 bps

€’m Reported Constant Currency Glanbia Nutritionals FY 2018 FY 2017 FY 2017 % Change

Nutritional Solution 526.7 531.9 511.6 +3.0% US Cheese 680.0 734.1 702.0 (3.1%) Glanbia Nutritionals Revenue 1,206.7 1,266.0 1,213.6 (0.6%) Glanbia Nutritionals EBITA 111.8 113.5 108.5 +3.0% Glanbia Nutritionals EBITA margin 9.3% 9.0% 8.9% +40 bps

slide-31
SLIDE 31

31

€’m Reported Constant Currency Joint Ventures FY 2018 FY 2017 FY 2017 % Change

Revenue 1,283.8 1,093.4 1,075.7 +19.3% EBITA 65.8 63.4 62.4 +5.4% EBITA margin 5.1% 5.8% 5.8%

  • 70 bps

Share of JVs PAT 45.3 42.8 42.3 +7.1%

€’m Reported Constant Currency Total Group Revenue** FY 2018 FY 2017 FY 2017 % Change

Glanbia Performance Nutrition 1,179.6 1,121.1 1,077.7 +9.5% Glanbia Nutritionals 1,206.7 1,266.0 1,213.6 (0.6%) Wholly-owned Revenue 2,386.3 2,387.1 2,291.3 +4.1% Equity accounted investees 1,283.8 1,093.4 1,075.7 +19.3% 40% share of Discontinued operations* 143.2 143.2 Pro-forma Equity accounted investees 1,283.8 1,236.6 1,218.9 +5.3% Total Group Revenue 3,670.1 3,623.7 3,510.2 +4.6%

*Joint Venture numbers are on a reported basis and exclude Discontinued operations for FY 2017 **Total Group revenue is comprised of wholly-owned revenue plus Glanbia’s share of revenue of JVs. Total Group Revenue growth growth year-on-year compares 2018 actual results with 2017 pro-forma results which have been re-stated for FX movements. 2017 Pro-forma numbers adjust for the sale of 60% of Dairy Ireland on a continuing basis for FY 2017